Lucid Diagnostics Inc.
LUCDNasdaqCIK 1799011HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:34 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-048114 |
| 2026-10-1620:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-047404 |
| 2026-09-2213:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043659 |
| 2026-08-1312:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037596 |
| 2026-08-1220:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027335 |
| 2026-06-2421:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029943 |
| 2026-05-1412:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022877 |
| 2026-05-1320:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016751 |
| 2026-04-3021:00 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020708 |
| 2026-04-2420:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018926 |
| 2026-04-2320:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018725 |
| 2026-03-2612:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012807 |
| 2026-03-2520:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009805 |
| 2026-02-0923:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001094891-26-000053 |
| 2025-11-1213:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021748 |
| 2025-11-1213:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021737 |
| 2025-10-1001:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-017859 |
| 2025-09-2512:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-014872 |
| 2025-09-1113:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013046 |
| 2025-09-1013:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012962 |
| 2025-08-1312:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011882 |
| 2025-08-1221:29 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011862 |
| 2025-06-1821:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015613 |
| 2025-05-3020:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-013059 |
| 2025-05-1412:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010101 |
| 2025-05-1320:58 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009986 |
| 2025-04-3020:15 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007766 |
| 2025-04-2520:44 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006239 |
| 2025-04-1113:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003740 |
| 2025-04-1012:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-003526 |
| 2025-03-2512:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000514 |
| 2025-03-2412:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000205 |
| 2025-03-0521:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009231 |
| 2025-03-0413:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008980 |
| 2025-03-0412:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-008974 |
| 2025-02-2523:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-008100 |
| 2024-12-2021:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-051061 |
| 2024-12-1221:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-049793 |
| 2024-11-2921:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-048170 |
| 2024-11-1822:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-046587 |
| 2024-11-1313:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044974 |
| 2024-11-1221:36 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044799 |
| 2024-11-1212:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-044502 |
| 2024-08-1212:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031168 |
| 2024-08-1212:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-031161 |
| 2024-07-2422:54 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-028854 |
| 2024-06-2121:15 ET | 8-K | 3.01 Delisting notice | 0001493152-24-024793 |
| 2024-06-0613:48 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001493152-24-022864 |
| 2024-05-2420:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021374 |
| 2024-05-1410:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-019020 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.